Epitopic analysis of the Toxoplasma gondii major surface antigen SAG1.

T and B cell epitopes of the major Toxoplasma gondii surface antigen SAG1 were studied following CNBr fragmentation. Three fragments, F1, F2 and F3, were obtained, of 19, 16.5 and 14 kDa, respectively. The positions of F1 F2 and F3 within the SAG1 protein were identified by N-terminal sequence determination. The F1 fragment located on residues 125-269 contains the C-terminus, and the fragment F2 (residues 1-124) is located at the N-terminal region. F3 is a C-terminal peptide about 40 amino acids shorter than the F1 fragment (residues 165-269). Polyclonal antibodies obtained from infected animals or humans and a monoclonal anti-SAG1 antibody did not recognize either the reduced protein or the reduced fragments on immunoblotting. The monoclonal antibody 1E5 did not recognize fragment F1. Mouse IgA and IgG antibodies from infected mouse sera and intestinal secretions, as well as human IgG antibodies, only recognized the whole protein and the F1 fragment. These results suggest that the fragment F1 encompasses all B cell epitopes recognized on the SAG1 protein after infection with the parasite and that the sequence 125-165 is essential for the structural integrity of these B cell epitopes. Murine anti-SAG1 T cell proliferation was observed in SAG1 immunized CBA/J mice (H-2k) and BALB/c mice (H-2d), but not in C57BL/6 mice (H-2b). The three fragments F1, F2 and F3 were able to induce specific proliferation of anti-SAG1 T cells from CBA/J mice, while only the F1 and F2 fragments induced specific blastogenesis of anti-SAG1 T cells from BALB/c mice.(ABSTRACT TRUNCATED AT 250 WORDS)

[1]  J. Dubremetz,et al.  Antibody responses to Toxoplasma gondii in sera, intestinal secretions, and milk from orally infected mice and characterization of target antigens , 1990, Infection and immunity.

[2]  D. Bout,et al.  Mucosal and systemic cellular immune responses induced by Toxoplasma gondii antigens in cyst orally infected mice. , 1993, Immunology.

[3]  J. Boothroyd,et al.  Molecular analysis of the gene encoding the major surface antigen of Toxoplasma gondii. , 1988, Journal of immunology.

[4]  R. Schwarz,et al.  Evidence for glycosyl-phosphatidylinositol anchoring of Toxoplasma gondii major surface antigens , 1989, Molecular and cellular biology.

[5]  U. Canosi,et al.  Cyanogen bromide cleavage at methionine residues of polypeptides containing disulfide bonds. , 1989, Analytical biochemistry.

[6]  I. Khan,et al.  A purified parasite antigen (p30) mediates CD8+ T cell immunity against fatal Toxoplasma gondii infection in mice. , 1991, Journal of immunology.

[7]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[8]  L. Kasper,et al.  Purification of a major membrane protein of Toxoplasma gondii by immunoabsorption with a monoclonal antibody. , 1983, Journal of immunology.

[9]  Elizabeth Simpson,et al.  A rapid method for the isolation of functional thymus‐derived murine lymphocytes , 1973, European journal of immunology.

[10]  J. Boothroyd,et al.  Antigen-specific (p30) mouse CD8+ T cells are cytotoxic against Toxoplasma gondii-infected peritoneal macrophages. , 1992, Journal of immunology.

[11]  M. Waldor,et al.  Depletion of T-4+ lymphocytes with monoclonal antibody reactivates toxoplasmosis in the central nervous system: a model of superinfection in AIDS. , 1987, Journal of immunology.

[12]  Y. Suzuki,et al.  Dual regulation of resistance against Toxoplasma gondii infection by Lyt-2+ and Lyt-1+, L3T4+ T cells in mice. , 1988, Journal of immunology.

[13]  J. Boothroyd,et al.  Protection of mice from fatal Toxoplasma gondii infection by immunization with p30 antigen in liposomes. , 1991, Journal of immunology.

[14]  E. Gross [27] The cyanogen bromide reaction , 1967 .

[15]  R. McLeod,et al.  Secretory IgA specific for Toxoplasma gondii. , 1986, Journal of immunology.

[16]  D. Vinatier,et al.  Anti‐P30 IgA antibodies as prenatal markers of congenital toxoplasma infection , 1992, Clinical and experimental immunology.

[17]  A. Sher,et al.  Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. , 1991, Journal of immunology.

[18]  J. Couvreur,et al.  Congenital toxoplasmosis. A prospective study of 378 pregnancies. , 1974, The New England journal of medicine.

[19]  A. Capron,et al.  Protection of mice and nude rats against toxoplasmosis by a multiple antigenic peptide construction derived from Toxoplasma gondii P30 antigen. , 1992, Journal of immunology.

[20]  M. Gefter,et al.  Modulation of restricted class II T cell responses by peptides derived from self class II molecule , 1992, European journal of immunology.

[21]  A. Strosberg,et al.  Haplotype specific homology scanning algorithim to predict T‐cell epitopes from protein sequences , 1991, Journal of molecular recognition : JMR.

[22]  A Sette,et al.  Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad. , 1992, Science.